Filter

Refine by Access

Refine by Date

—
  • Print
  • Save

Browse

You are looking at 101 - 110 of 3,806 items for

  • Refine by Access: All x
Clear All
Full access

CLO22-074: Patient-Reported Outcomes (PROs) in Patients (pts) With Advanced Non-Small Cell Lung Cancer (aNSCLC) With Programmed Cell Death-Ligand 1 (PD-L1) ≥50% Receiving Cemiplimab (CEMI) Monotherapy Versus Platinum-Doublet Chemotherapy (CHEMO): A Focus on the EMPOWER-Lung 1 Brain Metastases Subpopulation

Mustafa Özgüroğlu, Ahmet Sezer, Saadettin Kilickap, Mahmut Gümüş, Igor Bondarenko, Miranda Gogishvili, Xuanyao He, Jennifer McGinniss, Giuseppe Gullo, Petra Rietschel, and Ruben GW Quek

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

CLO22-075: Hereditary Retinoblastoma: Same Disease, Different Aetiologies

Ana Carolina Tamayo Palacio, Alejandra del Pilar Reyes de la Rosa, Perla Rocio Robledo Ramirez, Nidia Anaid Huerta Bolfeta, Linda Beatriz Muñoz Martinez, Ariadna Berenice Morales Jimenez, and Rodrigo Moreno Salgado

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

CLO22-078: Dual-Tracer PET/CT-Targeted, mpMRI-Targeted, Systematic Biopsy, and Combined Biopsy for the Diagnosis of Prostate Cancer

Dong-Xu Qiu, Jian Li, Jin-Wei Zhang, Min-Feng Chen, Xiao-Mei Gao, Yong-Xiang Tang, Ye Zhang, Xiao-Ping Yi, Hong-ling Yin, Yu Gan, Gui-Lin Wang, Xiong-Bing Zu, Shuo Hu, and Yi Cai

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

CLO22-079: A Phase II Open-Label Study of Subcutaneous CpG ODN (PF03512676) in Combination With Trastuzumab in Patients With Metastatic Breast Cancer

Dionisia Marie Quiroga, Ashley Pinette, Brooke Benner, Emily Schwarz, Robert Wesolowski, Andrew Stiff, Sara Zelinskas, Erin Macrae, Maryam Lustberg, Ewa Mrozek, Bhuvaneswari Ramaswamy, and William E Carson III

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

CLO22-080: Correlation of Imaging and Biochemical Modalities in Identifying the Exact Anatomical Site of Origin of Tumour in Periampullary Carcinoma – A Prospective Observational Study

Satyaki Roy, Rajesh Gupta, Vikas Gupta, Harjeet Singh, Mandeep Kang, Surinder Rana, Ritambhara Nada, and Yashwant Kumar

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

CLO22-081: Clinical Efficacy and Quality of Life of Oral Cancer Patients Treated With Paclitaxel/Cisplatin/5-FU Vs Paclitaxel/Carboplatin Chemotherapeutic Regimens in a Tertiary Cancer Center in Eastern India

Pranab Kumar Sahoo, Sinjini Sarkar, Sutapa Mahata, Ranita Pal, Tanuma Mistry, Sushmita Ghosh, Trisha Choudhury, Sriparna Datta, Anup Kumar Bhowmick, Kalyan Kusum Mukherjee, and Vilas D Nasare

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

CLO22-082: Texture Feature Analysis With C11 Methionine in Glioma on Simultaneous PET/MRI

Vishnu Sampathkumar,, Dinesh Kumar, Nisarga Prasad, Pardeep Kumar Singh, Jitender Saini, Nishanth Sadhashiv, Uday Krishna, and Chandana Nagaraj

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

CLO22-083: Impact of Body Mass Index (BMI) on the Unplanned Need for Whole Breast Radiation Therapy (WBRT) Following Intra-Operative Electronic Brachyterapy for Early-Stage Breast Cancer

Barbara S Schwartzberg, A. M. Nisar Syed, and Craig Wengler

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

CLO22-084: Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Previously Treated Metastatic Colorectal Cancer: A Multicenter Retrospective Analysis With Focus on Elderly Patients Subgroup

Carlo Signorelli, Federica Zoratto, Donatello Gemma, Rosa Saltarelli, Maria Grazia Morandi, Roberta Grande, Gian Paolo Spinelli, Salvatore De Marco, Isabella Sperduti, Mario Giovanni Chilelli, Anna Ceribelli, and Enzo Maria Ruggeri

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022
Full access

CLO22-085: A Dual-Center Retrospective Cohort Validation of the 2021 NCCN Risk Stratification for Cutaneous Squamous Cell Carcinoma

Jacqueline S. Stevens, Fadi Murad, Timothy D. Smile, Shlomo Koyfman, Abigail B. Waldman, Emily S. Ruiz, and Chrysalyne D. Schmults

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 20 (2022): Issue 3.5 (Mar 2022): Abstracts from the NCCN 2022 Virtual Annual Conference

31 Mar 2022